4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
9.66
+1.34 (16.11%)
At close: Oct 8, 2025, 4:00 PM EDT
9.74
+0.08 (0.83%)
After-hours: Oct 8, 2025, 7:47 PM EDT
4D Molecular Therapeutics Market Cap
4D Molecular Therapeutics has a market cap or net worth of $451.15 million as of October 8, 2025. Its market cap has decreased by -27.05% in one year.
Market Cap
451.15M
Enterprise Value
57.19M
1-Year Change
-27.05%
Ranking
Category
Stock Price
$9.66
Market Cap Chart
Since the IPO on December 11, 2020, 4D Molecular Therapeutics's market cap has decreased from $580.38M to $451.15M, a decrease of -22.27%. That is a compound annual growth rate of -5.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 388.56M | 50.91% |
| Dec 31, 2024 | 257.49M | -70.27% |
| Dec 29, 2023 | 866.19M | 20.40% |
| Dec 30, 2022 | 719.43M | 2.03% |
| Dec 31, 2021 | 705.13M | -35.79% |
| Dec 31, 2020 | 1.10B | 89.22% |
| Dec 11, 2020 | 580.38M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 760.60B |
| Johnson & Johnson | 453.25B |
| AbbVie | 403.56B |
| UnitedHealth Group | 325.45B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 232.89B |